Antibiotic Selection and Dosing in Chronic Kidney Disease

Introduction to Antibiotic Use in CKD

The American College of Physicians and the Infectious Diseases Society of America recommend that antibiotic selection in patients with chronic kidney disease (CKD) must be based on the specific infection type, causative organism, and severity of renal impairment, with dose adjustment according to creatinine clearance being the critical safety measure rather than choosing one agent over another 1, 2

Aminoglycosides should not be used unless no suitable, less nephrotoxic alternatives are available, as recommended by the National Kidney Foundation 3
The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines suggest that if aminoglycosides must be used in patients with normal kidney function, they should be administered as single daily dosing rather than multiple daily doses 3
Conventional amphotericin B should be replaced with azole antifungals or echinocandins when equal therapeutic efficacy can be assumed, according to the Infectious Diseases Society of America 3
If amphotericin B is necessary and creatinine rises above 2.5 mg/dL, the American College of Clinical Pharmacy recommends switching to lipid-associated formulations which are less nephrotoxic 4, 5

For patients with CKD, the American College of Clinical Pharmacy recommends reducing the frequency of fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin) to every 12 hours when CrCl is 30-50 mL/min, and to every 18-24 hours when CrCl is <30 mL/min 1, 2
For hemodialysis patients, the National Kidney Foundation recommends dosing fluoroquinolones at 250-500 mg every 24 hours, post-dialysis 1, 2
The Infectious Diseases Society of America recommends that vancomycin dosing should be adjusted for renal function, with a recommended dose of 15-20 mg/kg/dose IV every 8-12 hours 6
For patients with CKD, the American College of Clinical Pharmacy recommends reducing the dose of macrolides (e.g., Clarithromycin) by 50% when CrCl is <30 mL/min 1, 2

Clindamycin can be administered at 600 mg IV every 8 hours regardless of CKD stage, as recommended by the American College of Clinical Pharmacy 6, 7
Linezolid can be administered at 600 mg IV/PO twice daily without modification, according to the Infectious Diseases Society of America 6

The American College of Physicians recommends calculating creatinine clearance accurately, using 24-hour urine collection rather than estimating formulas when trimethoprim or pyrimethamine are being used 8
The National Kidney Foundation suggests selecting antibiotics based on their safety profile, with first choice being antibiotics not requiring dose adjustment (e.g., clindamycin, linezolid) 6, 7
The Infectious Diseases Society of America recommends avoiding nephrotoxic agents (e.g., aminoglycosides, conventional amphotericin B) when possible 3, 4, 5

The American College of Clinical Pharmacy recommends monitoring for clinical improvement within 48-72 hours of initiating therapy, and implementing therapeutic drug monitoring when available, especially for aminoglycosides and vancomycin 3, 6
The National Kidney Foundation suggests monitoring for antibiotic-related toxicity, including Clostridioides difficile-associated diarrhea with clindamycin 6